118 related articles for article (PubMed ID: 35932580)
1. KDM2A plays a dual role in regulating the expression of malignancy-related genes in esophageal squamous cell carcinoma.
Wang J; Zhang ZY; Jiang J; Tang L; Wang XY; Wang Z; Yang XL; Yu XL; Huang CC; Chen F; Wan HS; Ye SJ
Biochem Biophys Res Commun; 2022 Oct; 624():53-58. PubMed ID: 35932580
[TBL] [Abstract][Full Text] [Related]
2. Mammalian lysine histone demethylase KDM2A regulates E2F1-mediated gene transcription in breast cancer cells.
Rizwani W; Schaal C; Kunigal S; Coppola D; Chellappan S
PLoS One; 2014; 9(7):e100888. PubMed ID: 25029110
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional repression of histone deacetylase 3 by the histone demethylase KDM2A is coupled to tumorigenicity of lung cancer cells.
Dhar SS; Alam H; Li N; Wagner KW; Chung J; Ahn YW; Lee MG
J Biol Chem; 2014 Mar; 289(11):7483-96. PubMed ID: 24482232
[TBL] [Abstract][Full Text] [Related]
4. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
5. Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer.
Liu H; Liu L; Holowatyj A; Jiang Y; Yang ZQ
Mol Carcinog; 2016 May; 55(5):977-90. PubMed ID: 26207617
[TBL] [Abstract][Full Text] [Related]
6. KDM6B promotes ESCC cell proliferation and metastasis by facilitating C/EBPβ transcription.
Qin M; Han F; Wu J; Gao FX; Li Y; Yan DX; He XM; Long Y; Tang XP; Ren DL; Gao Y; Dai TY
BMC Cancer; 2021 May; 21(1):559. PubMed ID: 34001062
[TBL] [Abstract][Full Text] [Related]
7. Histone demethylase KDM2A suppresses EGF-TSPAN8 pathway to inhibit breast cancer cell migration and invasion in vitro.
Zhang H; Tu Y; Huang B; Xiao J; Xiao J; Wang J; Pei Y; Yang R; Feng J; Li J; Zhang X
Biochem Biophys Res Commun; 2022 Nov; 628():104-109. PubMed ID: 36084547
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of KDM2A inhibits proliferation associated with TGF-β expression in HEK293T cell.
Xu WH; Liang DY; Wang Q; Shen J; Liu QH; Peng YB
Mol Cell Biochem; 2019 Jun; 456(1-2):95-104. PubMed ID: 30604066
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA circFOXO3 regulates KDM2A by targeting miR-214 to promote tumor growth and metastasis in oral squamous cell carcinoma.
Ai Y; Wu S; Zou C; Wei H
J Cell Mol Med; 2022 Mar; 26(6):1842-1852. PubMed ID: 34117688
[TBL] [Abstract][Full Text] [Related]
10. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ
J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985
[TBL] [Abstract][Full Text] [Related]
11. Histone H3K36me2 demethylase KDM2A promotes bladder cancer progression through epigenetically silencing RARRES3.
Lu B; Wei J; Zhou H; Chen J; Li Y; Ye L; Zhao W; Wu S
Cell Death Dis; 2022 Jun; 13(6):547. PubMed ID: 35697678
[TBL] [Abstract][Full Text] [Related]
12. Mild Glucose Starvation Induces KDM2A-Mediated H3K36me2 Demethylation through AMPK To Reduce rRNA Transcription and Cell Proliferation.
Tanaka Y; Yano H; Ogasawara S; Yoshioka S; Imamura H; Okamoto K; Tsuneoka M
Mol Cell Biol; 2015 Dec; 35(24):4170-84. PubMed ID: 26416883
[TBL] [Abstract][Full Text] [Related]
13. Expression pattern and regulatory effect of lysine-specific demethylase 2A gene in clear cell renal cell carcinoma.
Wang J; Li T; Li X; Zhang Y; Wang X
BMC Urol; 2021 Aug; 21(1):108. PubMed ID: 34391411
[TBL] [Abstract][Full Text] [Related]
14. Depletion of histone demethylase KDM2A inhibited cell proliferation of stem cells from apical papilla by de-repression of p15INK4B and p27Kip1.
Gao R; Dong R; Du J; Ma P; Wang S; Fan Z
Mol Cell Biochem; 2013 Jul; 379(1-2):115-22. PubMed ID: 23559091
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑3666 suppresses the growth and migration of glioblastoma cells by targeting KDM2A.
Shou T; Yang H; Lv J; Liu D; Sun X
Mol Med Rep; 2019 Feb; 19(2):1049-1055. PubMed ID: 30483744
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
Wu D; He X; Wang W; Hu X; Wang K; Wang M
Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
[TBL] [Abstract][Full Text] [Related]
17. Lysine-Specific Histone Demethylase 1 Promotes Oncogenesis of the Esophageal Squamous Cell Carcinoma by Upregulating DUSP4.
Han J; Ye S; Chen J; Wang K; Jin J; Zeng Z; Xue S
Biochemistry (Mosc); 2021 Dec; 86(12):1624-1634. PubMed ID: 34937541
[TBL] [Abstract][Full Text] [Related]
18. HPV16 E7-induced upregulation of KDM2A promotes cervical cancer progression by regulating miR-132-radixin pathway.
Ou R; Zhu L; Zhao L; Li W; Tao F; Lu Y; He Q; Li J; Ren Y; Xu Y
J Cell Physiol; 2019 Mar; 234(3):2659-2671. PubMed ID: 30132864
[TBL] [Abstract][Full Text] [Related]
19. Lysine demethylase 2A promotes stemness and angiogenesis of breast cancer by upregulating Jagged1.
Chen JY; Li CF; Chu PY; Lai YS; Chen CH; Jiang SS; Hou MF; Hung WC
Oncotarget; 2016 May; 7(19):27689-710. PubMed ID: 27029061
[TBL] [Abstract][Full Text] [Related]
20. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
